DekaBank Deutsche Girozentrale Sells 3,562 Shares of The Chemours Company (NYSE:CC)

DekaBank Deutsche Girozentrale lessened its stake in shares of The Chemours Company (NYSE:CC) by 77.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 1,033 shares of the specialty chemicals company’s stock after selling 3,562 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Chemours were worth $33,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in CC. Legacy Financial Group LLC acquired a new stake in shares of Chemours in the 3rd quarter valued at $29,000. Atlas Capital Advisors LLC acquired a new stake in shares of Chemours in the 2nd quarter valued at $52,000. Anchor Investment Management LLC acquired a new stake in shares of Chemours in the 4th quarter valued at $56,000. Steward Partners Investment Advisory LLC boosted its holdings in shares of Chemours by 117.2% in the 1st quarter. Steward Partners Investment Advisory LLC now owns 2,098 shares of the specialty chemicals company’s stock valued at $63,000 after purchasing an additional 1,132 shares in the last quarter. Finally, IFP Advisors Inc boosted its holdings in shares of Chemours by 39.0% in the 3rd quarter. IFP Advisors Inc now owns 2,232 shares of the specialty chemicals company’s stock valued at $63,000 after purchasing an additional 626 shares in the last quarter. Institutional investors own 76.26% of the company’s stock.

Chemours Stock Down 0.2 %

Shares of CC opened at $26.37 on Thursday. The company has a market capitalization of $3.93 billion, a PE ratio of -17.01 and a beta of 2.00. The Chemours Company has a 12 month low of $15.10 and a 12 month high of $39.05. The stock’s 50-day moving average price is $27.05 and its two-hundred day moving average price is $27.81. The company has a current ratio of 1.54, a quick ratio of 1.00 and a debt-to-equity ratio of 5.40.

Chemours Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 3.79%. The ex-dividend date of this dividend was Friday, February 23rd. Chemours’s payout ratio is presently -64.52%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. UBS Group raised their target price on Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a report on Tuesday, April 2nd. Barclays cut their price objective on Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 2nd. Finally, BMO Capital Markets raised Chemours from an “underperform” rating to an “outperform” rating and raised their price objective for the company from $19.00 to $34.00 in a report on Tuesday, April 9th. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, Chemours has a consensus rating of “Hold” and a consensus price target of $30.89.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.